Promoter methylation of glutathione S‐transferase π1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression |
| |
| Authors: | Peng Gao MD Xi Yang MD Yu‐Wen Xue MD Xiao‐Fang Zhang MD Yan Wang MD Wen‐Jun Liu MD Xiao‐Juan Wu MD |
| |
| Affiliation: | 1. Department of Pathology, School of Medicine, Shandong University, Jinan, People's Republic of China;2. Fax: (011) 86‐531‐88382052;3. The first two authors contributed equally to this article.;4. Department of Pulmonary Medicine, Qilu Hospital, Shandong University, Jinan, People's Republic of China |
| |
| Abstract: | BACKGROUND: The presence of glutathione S‐transferase (GST) π1 (GSTP1) or multidrug resistance gene 1 (MDR1) promoter methylation in lung cancer was studied for the first time to the authors' knowledge; and, to date, the clinical significance of methylation is not clear. The objective of the current study was to determine the promoter methylation status of GSTP1 and MDR1, which encode GST‐π and P‐glycoprotein (Pgp), respectively, in patients with bronchioloalveolar carcinoma (BAC) and to investigate whether methyltransferase 1 (DNMT1)‐mediated GSTP1 or MDR1 methylation are responsible for disease progression and prognosis in patients with BAC. METHODS: Protein expression levels of DNTM1, GST‐π, and Pgp were determined by immunohistochemistry in samples from 36 patients with BAC. Promoter methylation status of the GSTP1 and MDR1 genes was determined by using methylation‐specific polymerase chain reaction analysis. RESULTS: The results demonstrated a significant correlation between the methylation of the GSTP1 or MDR1 promoters and negative expression of their respective proteins in BAC (P < .05). A significant correlation also was demonstrated between GSTP1 methylation and recurrence‐free and overall survival of patients with BAC. DNMT1 protein expression levels were correlated with GSTP1 promoter methylation and patient prognosis (P < .05). However, no correlation was observed between DNMT1 expression and MDR1 methylation. CONCLUSIONS: GSTP1 promoter methylation mediated by DNMT1 may promote BAC progression and could serve as a poor prognostic indicator for patients with this disease. DNMT1 protein expression also may be considered as a prognostic indicator. Methylation of the MDR1 promoter may be mediated through pathways other than DNMT1 in BAC and does not appear to be associated with disease progression or patient prognosis. Cancer 2009. © 2009 American Cancer Society. |
| |
| Keywords: | glutathione S‐transferase π 1 DNA methyltransferase 1 methylation prognosis bronchioloalveolar carcinoma |
|
|
